Select your language
A phase I/II randomized study to determine the maximum tolerated dose (MTD), safety, pharmacokinetics and antitumor activity of Debio 1143 combined with concurrent chemo-radiation therapy in patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN).
Coordinator : Prof. BOURHIS
Start date : 2016
Number of patients : 96
Phase II randomized study of RT cisplatin 100 versus weekly fractionated.
Coordinator : Dr Borel
Start date : 2016
Expected number of patients : 124
Access the Clinical Trials link
Access detailed information on the trial in the private section
Randomized, double-blind, placebo-controlled phase III trial to evaluate the efficacy of BIBW 2992 (afatinib) in maintenance therapy after postoperative radio-chemotherapy in squamous cell carcinoma of the upper aerodigestive tract
Coordinator : DR RACADOT - DR POMMIER
Start date : 2011
Number of patients 315
Access the Clinical Trials link
Access detailed information on the trial in the private section
Phase III trial evaluating the benefit of an oral immune modulating solution in the prevention of severe acute mucositis following chemotherapy
Coordinator : Dr SENESSE - Dr BOISSELIER
Start date : 2012
Number of patients 180
Access the Clinical Trials link
Access detailed information on the trial in the private section
Phase III trial comparing Extreme versus TPEx as a first-line treatment in recurrent and/or metastatic HNSCC.
Coordinator : Prof. Guigay
Start date : 2015
Expected number of patients : 416
Access the Clinical Trials link
Access detailed information on the trial in the private section
Randomized, phase III study comparing intensity-modulated conformal radiotherapy (IMRT) with conventional radiotherapy for stage III and IV carcinoma of the upper aerodigestive tract.
Coordinator : Prof. BOURHIS
Start date : 2005
Expected number of patients 310
Access the Clinical Trials link
Access detailed information on the trial in the private section
Multicenter, randomized, phase III trial evaluating the benefit of concomitant chemotherapy in patients receiving radiotherapy - Erbitux for locally advanced carcinoma of the upper aerodigestive tract <= N2a.
Coordinator : Prof. BOURHIS
Start date : 2008
Number of patients 406
Access the Clinical Trials link
Access detailed information on the trial in the private section
Randomized, multicenter Phase III study, comparing an induction chemotherapy with TPF followed by radiotherapy and concurrent Erbitux® versus chemoradiotherapy for patients with inoperable locally advanced squamous cell carcinoma of the upper aerodigestive tract >=N2b
Coordinator : Dr GEOFFROIS
Start date : 2009
Number of patients 360
Access the Clinical Trials link
Access detailed information on the trial in the private section
GORTEC 99-02 phase III randomized trial, conventional radiotherapy + concomitant chemoradiotherapy versus accelerated radiotherapy + concomitant chemotherapy versus very accelerated radiotherapy in upper aerodigestive tract carcinoma
Coordinator : Prof. BOURHIS
Start date : 2000
Number of patients : 840
Access detailed information on the trial in the private section
Randomized phase II study comparing TPF followed by RT-Erbitux versus TPF followed by RT-cisplatin for larynx preservation
Coordinator : Prof. LEFEBVRE
Start date : 2004
Number of patients : 153
Access detailed information on the trial in the private section
Concomitant radiochemotherapy vs radiotherapy alone in the treatment of locally advanced squamous cell carcinoma of the upper aerodigestive tract.
Coordinator : Prof. CALAIS
Start date : 1994
Number of patients : 226
Access detailed information on the trial in the private section
Very accelerated radiochemotherapy vs conventional radiotherapy in the treatment of locally advanced squamous cell carcinoma of the upper aerodigestive tract.
Coordinator : Prof. BOURHIS
Start date : 1994
Number of patients : 268
Access detailed information on the trial in the private section
Phase II study evaluating the combination of cisplatin, 5FU and concomitant radiotherapy in patients having undergone surgery at high risk of recurrence.
Coordinator : Dr GEOFFROIS
Start date : 2000
Number of patients : 61
Access detailed information on the trial in the private section
Larynx preservation - Phase II randomized trial comparing TPF versus PF in larynx preservation
Coordinator : Prof. CALAIS
Start date : 2000
Number of patients : 215
Access detailed information on the trial in the private section
Phase III randomized trial evaluating re-irradiation and concomitant chemotherapy following salvage surgery.
Coordinator : Dr JANOT
Start date : 2001
Number of patients : 125
Access detailed information on the trial in the private section
Phase I/II, two-center, dose escalation study of oral Etoposide + conventional radiotherapy in carcinoma of the upper aerodigestive tract.
Coordinator Prof. BOURHIS / Dr Tao / Dr Bardet
Start date : 2005
Number of patients : 16
Access detailed information on the trial in the private section
Title Phase I dose escalation study by IMRT in stages I and II
Coordinator : Prof. GREGOIRE / Prof. MAINGON
Start date 2006
Access detailed information on the trial in the private section
Phase II study of sunitinib in recurrent or metastatic squamous cell carcinoma of the head and neck
Coordinator : DR MACHIELS
Start date : 2006
Number of patients : 38
Access detailed information on the trial in the private section
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck : GORTEC 2008-02.
Coordinator : DR MACHIELS / Prof. GUIGAY
Start date : 2008
Access detailed information on the trial in the private section
Assessment of circulating tumor cells as an early predictive marker of response to treatment.
Coordinator : Dr CUPISSOL - Dr PANABIERES - Dr COSTES - Dr GABREL
Start date : 2013
Number of patients 110
Access the Clinical Trials link
Access detailed information on the trial in the private section
Multicenter, randomized trial evaluating the effect of OTD70DERM® on radiation-induced dermatitis caused by the combination of radiotherapy-Erbitux®
Coordinator : Dr TAO / Prof. BOURHIS
Start date : 2010
Number of patients 70
Access the Clinical Trials link
Access detailed information on the trial in the private section
Phase II study evaluating the combination of cetuximab, docetaxel and cisplatin as first-line treatment of metastatic or recurrent squamous cell carcinoma of the head and neck.
Coordinator : Prof. GUIGAY
Start date : 2009
Number of patients : 54
Access detailed information on the trial in the private section
Randomized, multicenter, phase III trial comparing induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) followed by concurrent chemotherapy-radiotherapy to concurrent chemotherapy-radiotherapy alone, in nasopharyngeal cancers staged as T2b, T3, T4 and/or with lymph node involvement (>N1)
Coordinator : Prof. FRIKHA - Prof. DAOUD - Prof. BOURHIS
Start date : 2008
Number of patients 83
Access the Clinical Trials link
Access detailed information on the trial in the private section
Concurrent accelerated radiotherapy and chemotherapy vs accelerated radiotherapy alone in inoperable N3 locally advanced squamous cell carcinoma of the upper aerodigestive tract. Phase II randomized study
Coordinator : Prof. BOURHIS
Start date : 1996
Number of patients : 109
Access detailed information on the trial in the private section
Phase III randomized trial - Re-irradiation and 5FU-Hydrea versus methotrexate in the palliative treatment of recurrent upper aerodigestive tract carcinoma in an irradiated area
Coordinator : Dr TORTOCHAUX
Start date : 1998
Number of patients : 60
Access detailed information on the trial in the private section
Functional update - Phase III randomized trial comparing TPF versus PF in larynx preservation
Coordinator : Prof. CALAIS
Start date : 2000
Number of patients : 220
Access detailed information on the trial in the private section